Skip to content

Clinical trials

Lymphoma, T-Cell trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell Country / region: Australia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20081
20111
20131
20192
20201
20221
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated4
Recruiting3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
Corvus Pharmaceuticals, Inc.2
CRISPR Therapeutics1
CRISPR Therapeutics AG1
Eli Lilly and Company1
Prelude Therapeutics1
Prescient Therapeutics, Ltd.1
Seagen Inc.1
Spectrum Pharmaceuticals, Inc1
Therapeutic Advances in Childhood Leukemia Consortium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell13
Lymphoma, Non-Hodgkin5
Lymphoma4
Lymphoma, B-Cell3
Lymphoma, T-Cell, Peripheral3
Hematologic Neoplasms2
Leukemia, Myeloid, Acute2
Lymphoma, Large-Cell, Anaplastic2
Lymphoma, T-Cell, Cutaneous2
Lymphoproliferative Disorders2

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.